No Data
No Data
Proteomics International Partners With University of Oxford to Advance Endometriosis Study
Predictive diagnostics specialist Proteomics International Laboratories (ASX: PIQ) has signed an agreement with the University of Oxford to acquire approximately 600 patient plasma samples for a study into endometriosis.
Proteomics International Signs Agreement With University of Oxford for Endometriosis Study
Proteomics International Laboratories (ASX:PIQ) has partnered with the University of Oxford to acquire approximately 600 patient plasma samples for further clinical validation of its PromarkerEndo blo
Proteomics Says PromarkerD's US Launch Delayed
Proteomics International Laboratories (ASX:PIQ) said the US roll out of its PromarkerD predictive test for diabetic kidney disease, originally planned for Q2 of 2024, is now "likely to be delayed," ac
Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans
Proteomics International Laboratories Downgraded to Hold From Speculative Buy by Morgans
Proteomics International Laboratories Secures ISO 13485 Certification Renewal
Medical technology company Proteomics International Laboratories (ASX:PIQ) secured ISO 13485 recertification, which is valid for three years, according to a filing with the Australian Securities Excha
Proteomics International Laboratories Narrows Fiscal H1 Loss
Proteomics International Laboratories (ASX:PIQ) reported Friday a net loss of AU$3.8 million in the six months ended Dec. 31, 2023, narrowing from AU$4.0 million a year earlier. Loss per share remaine
No Data